Mary Ellen Hoehn
- Genetics top 5%
- Glioma Diagnosis and Treatment 12
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases 5
- Ophthalmology top 5%
- Ocular Oncology and Treatments 11
- Ocular Infections and Treatments 7
-
- Ophthalmology and Eye Disorders 7
-
- Meningioma and schwannoma management 7
-
- Pituitary Gland Disorders and Treatments 5
-
- Corneal Surgery and Treatments 5
- Co-authors
- Thomas E. MerchantMary E. SmithJay PershadThomas SpentzasAmar GajjarHeather M. ConklinMatthew W. WilsonE. Brannon Morris
- Cited by
- GeneticsNeurologyOphthalmology
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Mary Ellen Hoehn
41 papers receiving 699 citations
Peers
Comparison fields: 5 of 77
- Genetics 288
- Neurology 308
- Ophthalmology 134
- Critical Care and Intensive Care Medicine 29
- Pediatrics, Perinatology and Child Health 96
Countries citing papers authored by Mary Ellen Hoehn
This map shows the geographic impact of Mary Ellen Hoehn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Hoehn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Hoehn more than expected).
Fields of papers citing papers by Mary Ellen Hoehn
This network shows the impact of papers produced by Mary Ellen Hoehn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Hoehn. The network helps show where Mary Ellen Hoehn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Ellen Hoehn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 34 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 18 | |
| 10 | 2018 | 10 | |
| 11 | 2018 | 10 | |
| 12 | Comparing Morbidity Rates in Retinopathy of Prematurity Treated with Either Intravitreal Bevacizumab or Conventional Laser Therapy | 2014 | 1 |
| 13 | 2013 | 5 | |
| 14 | 2010 | 159 | |
| 15 | 2010 | 3 | |
| 16 | 2010 | 16 | |
| 17 | 2009 | 136 | |
| 18 | 2008 | 7 | |
| 19 | 2007 | 31 | |
| 20 | 2004 | 37 |
About Mary Ellen Hoehn
Mary Ellen Hoehn is a scholar working on Ophthalmology, Genetics and Neurology, having authored 47 papers that have together received 715 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Ocular Oncology and Treatments (11 papers), Ocular Infections and Treatments (7 papers), Ophthalmology and Eye Disorders (7 papers), Meningioma and schwannoma management (7 papers), Pituitary Gland Disorders and Treatments (5 papers), Corneal Surgery and Treatments (5 papers) and Neurofibromatosis and Schwannoma Cases (5 papers). The work is most often cited by research in Genetics (288 citations), Neurology (308 citations) and Ophthalmology (134 citations). Mary Ellen Hoehn has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Thomas E. Merchant, Mary E. Smith, Jay Pershad, Thomas Spentzas, Amar Gajjar, Heather M. Conklin, Matthew W. Wilson, E. Brannon Morris, Gregory T. Armstrong and Melissa M. Hudson. Their work appears in journals such as Journal of Clinical Oncology, Neurology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.